Long-term follow-up of renal transplantation for Wegener's disease. 1990

P J Tzardis, and R W Gruessner, and A J Matas, and W D Payne, and D L Dunn, and D E Sutherland, and J S Najarian
Department of Surgery, University of Minnesota, Minneapolis.

Eight patients with end-stage renal failure due to Wegener's granulomatosis underwent renal transplantation at the University of Minnesota. Seven patients were alive with a functioning graft 40 to 128 months posttransplant (mean follow-up: 91 months). One patient died 126 months posttransplant with a well-functioning graft. Posttransplant immunosuppression controlled primary disease in all but 1 patient, who presented with perisinusitis. Recurrent disease was not noted in any of the transplanted organs. We conclude that transplantation is an excellent treatment for renal failure secondary to Wegener's disease.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011182 Postoperative Care The period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed) Care, Postoperative,Postoperative Procedures,Procedures, Postoperative,Postoperative Procedure,Procedure, Postoperative
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P J Tzardis, and R W Gruessner, and A J Matas, and W D Payne, and D L Dunn, and D E Sutherland, and J S Najarian
February 1993, Journal of pediatric surgery,
P J Tzardis, and R W Gruessner, and A J Matas, and W D Payne, and D L Dunn, and D E Sutherland, and J S Najarian
October 1992, Transplantation proceedings,
P J Tzardis, and R W Gruessner, and A J Matas, and W D Payne, and D L Dunn, and D E Sutherland, and J S Najarian
August 1973, The New England journal of medicine,
P J Tzardis, and R W Gruessner, and A J Matas, and W D Payne, and D L Dunn, and D E Sutherland, and J S Najarian
October 1976, Vrachebnoe delo,
P J Tzardis, and R W Gruessner, and A J Matas, and W D Payne, and D L Dunn, and D E Sutherland, and J S Najarian
November 2003, Transplantation proceedings,
P J Tzardis, and R W Gruessner, and A J Matas, and W D Payne, and D L Dunn, and D E Sutherland, and J S Najarian
January 1992, Journal of geriatric psychiatry and neurology,
P J Tzardis, and R W Gruessner, and A J Matas, and W D Payne, and D L Dunn, and D E Sutherland, and J S Najarian
March 2011, Rheumatology international,
P J Tzardis, and R W Gruessner, and A J Matas, and W D Payne, and D L Dunn, and D E Sutherland, and J S Najarian
January 1997, Transplantation proceedings,
P J Tzardis, and R W Gruessner, and A J Matas, and W D Payne, and D L Dunn, and D E Sutherland, and J S Najarian
September 1999, Transplantation proceedings,
P J Tzardis, and R W Gruessner, and A J Matas, and W D Payne, and D L Dunn, and D E Sutherland, and J S Najarian
June 1999, Journal of inherited metabolic disease,
Copied contents to your clipboard!